Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2005;4(1):43-7.
doi: 10.1007/s10689-004-1327-0.

Ophthalmological manifestations in VHL and NF 1: pathological and diagnostic implications

Affiliations
Review

Ophthalmological manifestations in VHL and NF 1: pathological and diagnostic implications

Klaus-Martin Kreusel. Fam Cancer. 2005.

Abstract

Von Hippel-Lindau disease (VHL) and neurofibromatosis type 1 (NF 1) are hereditary multitumor syndromes that show associated ocular manifestations. Capillary retinal angioma, a benign vascular tumor, is the classical ocular lesion in VHL. It often appears as the first manifestation of the disease and may thus lead to the diagnosis of VHL. Since small angiomas can be treated easily by laser photocoagulation, a regular ocular screening of VHL patients is recommended. Ocular manifestations of NF 1 are more diverse as compared to VHL. Lisch nodules of the iris are an important diagnostic criteria of NF 1 since they can be found in almost every affected patient. Optic glioma can occur both intraorbitally and intracranially. The intraorbital form causes progressive protrusion of the globe and eventually blindness. Extension of the tumor beyond the chiasm worsens the prognosis quoad vitam. The hallmark of NF 1, namely cutaneous neurofibroma can cause visual impairment when affecting the skin of the eyelids. The rare intraorbital pexiform neurofibroma is associated with abnormal development of the orbital bones and infantile glaucoma. It may result in orbital mass effects and therefore may need surgical excision.

PubMed Disclaimer

Similar articles

Cited by

References

    1. Ophthalmic Paediatr Genet. 1991 Mar;12(1):11-7 - PubMed
    1. Am J Ophthalmol. 1980 Apr;89(4):540-5 - PubMed
    1. Arch Ophthalmol. 1991 May;109(5):662-6 - PubMed
    1. J Pediatr. 1994 Jul;125(1):63-6 - PubMed
    1. J Pediatr. 1989 May;114(5):788-92 - PubMed

MeSH terms